Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
Parse Biosciences and Graph Therapeutics to create one of the largest and most comprehensive immune cell perturbation atlases.
The identification of drug-target Interactions (DTIs) represents a pivotal link in the process of drug development and design. It plays a crucial role in narrowing the screening range of candidate ...
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already known about genes, diseases, treatments, molecular pathways and symptoms in ...
UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive graph-based approach. The model is all about discovering new drug candidates in ...
Pharmaceutical-sector focussed AI startup Graph AI’s $3 Mn seed funding round was led by Bessemer Venture Partners The startup will use the capital for product innovation, team expansion, and ...
At a time when every enterprise looks to leverage generative artificial intelligence, data sites are turning their attention to graph databases and knowledge graphs. The global graph database market ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results